SEC Says Stem Cell Research Co. Execs Misled Investors
The Securities and Exchange Commission on Monday said they had charged and settled with two men in Massachusetts federal court accused of defrauding investors in a company they had substantial interest...To view the full article, register now.
Already a subscriber? Click here to view full article